Company: APM
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001213900-25-111548
Chunk: 315

Company: Aptorum Group Ltd
Filing Date: 2025-11-17
Form: F-1
Chunk 315
---
 related party transactions for potential conflict of interest situations and approving all such transactions; and                                                                                                                                                              |
| ● | reviewing the type and presentation of information to be included in our earnings press releases, as well as financial information and earnings guidance provided by us to analysts and rating agencies.                                                                                     |

194 Audit Committee Financial Expert We have one financial expert as of the date of this prospectus. Our Board of Directors has determined that Mr. Douglas Arner, Chair of our audit committee, qualifies as an “audit committee financial expert” as defined in the SEC rules and satisfies the financial sophistication requirements of The Nasdaq Capital Market. Mr. Arner is “independent” as that term is defined in the rules of the SEC and the applicable rules of the Nasdaq Capital Market. Compensation Committee Douglas Arner and Justin Wu (chair) currently serve on the compensation committee. Our Board of Directors has determined that each member of the compensation committee is “independent” as that term is defined in the applicable rules of the Nasdaq Capital Market. The compensation committee’s responsibilities include:

| ● | reviewing the goals and objectives of our executive compensation plans, as well as our executive compensation plans in light of such goals and objectives;                                                                             |
| ● | evaluating the performance of our executive officers in light of the goals and objectives of our executive compensation plans and recommending to our Board of Directors with respect to the compensation of our executive officers;   |
| ● | reviewing the goals and objectives of our general compensation plans and other employee benefit plans as well as our general compensation plans and other employee benefit plans in light of such goals and objectives;                |
| ● | retaining and approving the compensation of any compensation advisors;                                                                                                                                                                 |
| ● | reviewing all equity-compensation plans to be submitted for shareholder approval under the NASDAQ listing rules, and reviewing and approving all equity-compensation plans that are exempt from such shareholder approval requirement; |
| ● | evaluating the appropriate level of compensation for board and board committee service by non-employee directors; and                                                                                                                  |
| ● | reviewing and approving description of executive compensation included in our Annual Report on Form 20-F.                                                                                                                              |

Nominating and Corporate Governance Committee Douglas Arner (chair) and Justin Wu currently serve on the nominating and corporate governance committee, which is chaired by Professor Arner. Our Board of Directors has determined that each member of the nominating and corporate governance committee is “independent” as that term is defined in the applicable rules of the Nasdaq Capital Market. The nominating and corporate governance committee